At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 35 enrolled
Drug / intervention
topical prostaglandin analogsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Impact of Topical Prostaglandin Analogs on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma
In Brief
A Phase 4 clinical trial evaluating topical prostaglandin analogs for Glaucoma, Open-Angle. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the influence of topical prostaglandin analog (PGA) medication on corneal biomechanical properties in patients undergoing PGA treatment for open-angle glaucoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Open-Angle
CountriesCanada
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
First PostedMar 2015
Primary CompletionJun 2016
Study CompletionNov 2016
TodayJul 2026
First PostedMar 17, 2015
Enrollment StartMay 6, 2013
Primary CompletionJun 30, 2016
Study CompletionNov 16, 2016
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 11.3 years ago
Interventions
topical prostaglandin analogsdrug